162
Views
8
CrossRef citations to date
0
Altmetric
Original Article

High dead-space syringe use among people who inject drugs in Tijuana, Mexico

, MS, , DrPH, , MD, , PhD, , PhD, , MD & , PhD show all
Pages 220-225 | Received 11 Jul 2014, Accepted 14 Jan 2015, Published online: 19 Feb 2015

References

  • Magis-Rodriguez C, Brouwer KC, Morales S, Gayet C, Lazada R, Ortiz-Mondragon R. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-US border city of Tijuana. J Psychoactive Drugs 2005;37:333–339
  • Bucardo J, Brouwer KC, Magis-Rodriguez C, Ramos R, Fraga M, Perez SG. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend 2009;79:281–293
  • Ramos R, Ferreira-Pinto JB, Brouwer KC, Ramos ME, Lozada RM, Firestone-Cruz M. A tale of two cities: social and environmental influences shaping risk factors and protective factors in two Mexico-US border cities. Health Place 2009;15:999–1005
  • Strathdee SA, Lozada R, Ojeda VD, Pollini RA, Brouwer KC, Vera A, Cornelius W, et al. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS ONE 2008;3:e2690
  • White EF, Garfein RS, Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, Perez SG, et al. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica de Mexico 2007;49:165–172
  • Strathdee SA, Magis-Rodriguez C, Mays VM, Jimenez R, Patterson TL. The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response. Ann Epidemiol 2012;22:426–238
  • Instituto Nacional de Estadística y Geografía. Censo de población y vivienda 2010. 2011. Available from: http://www3.inegi.org.mx/sistemas/ResultadosR/CPV/Default.aspx?texto=tijuana [last accessed 3 March 2014]
  • Instituto Nacional de Geografia y Estadistica (INEGI). Mexico en cifras. Baja California. 2010. Available from: http://www3.inegi.org.mx/sistemas/mexicocifras/default.aspx?e=02 - T. [last accessed 21 October 2014]
  • Bae C-HC. Tijuana-San Diego: Globalization and the transborder metropolis. In: Richardson HW, Bae C-HC, eds. Globalization and the urban development. Los Angeles, CA: Springer; 2005. pp 181–196
  • Alarcon R, Becerra W. ¿Criminales o víctimas? La deportación de migrantes mexicanos de Estados Unidos a Tijuana, Baja California. [Criminals or victims? Mexican migrant deportation from the United States to Tijuana, Baja California]. Norteamerica 2012;7:125–148
  • Brouwer KC, Cornelius WA, Firestone-Cruz M, Magis-Rodriguez C, Zuniga de Nuncio ML, Strathdee SA. Deportation along the US-Mexico border: its relation to drug use patterns and accessing care. J Immigrant Minority Health 2009;11:1–6
  • Zule WA, Bobashev G, RTI International. High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. Drug Alcohol Depend 2009;100:204–213
  • Bobashev GV, Zule WA. Modeling the effect of high dead-space syringes on the human immunodeficiency virus (HIV) epidemic among injecting drug users. Addiction 2010;105:1439–1447
  • Thomas DL, Leoutsakas D, Zabransky T, Kumar MS. Hepatitis C in HIV-infected individuals: cure and control, right now. J Int AIDS Soc 2011;14:1–8
  • Robertson AM, Garfein RS, Wagner KD, Mehta SR, Magis-Rodriguez C, Cuevas-Mota J, Gonzalez P, Strathdee SA. Evaluating the impact of Mexico’s drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda. Harm Reduct J 2014;11:1--26
  • Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infectious Dis 2010;202:984–990
  • Strathdee SA, Lozada R, Pollini RA, Brouwer KC, Mantsios A, Abramovitz DA, Rhodes T, et al. Individual, social and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquired Immunodeficiency Synd 2008;47:369–376
  • Werb D, Wood E, Small W, Strathdee S, Li K, Montaner J, Kerr T. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy 2008;19:332–338
  • Volkmann T, Lozada R, Anderson CM, Patterson TL, Vera A, Strathdee SA. Factors associated with drug-related harms related to policing in Tijuana, Mexico. Harm Reduct J 2011;8:1–8
  • Pollini RA, Brouwer KC, Lozada RM, Ramos R, Cruz MF, Magis-Rodriguez C, Case P, et al. Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction 2007;103:101–108
  • Robertson A, Lozada R, Pollini RA, Rangel G, Ojeda VD. Correlates and contexts of US injection drug initiation among undocumented Mexican migrant men who were deported from the United States. AIDS Behav 2012;16:1670–1680
  • Pinedo M, Burgos JL, Robertson AM, Vera A, Lozada R, Ojeda VD. Perceived risk of HIV infection among deported male injection drug users in Tijuana, Mexico. Global Public Health 2014;9:436--454
  • Ojeda VD, Robertson AM, Hiller SP, Lozada R, Cornelius W, Palinkas LA, Magis-Rodriguez C, Strathdee SA. A qualitative view of drug use behaviors of Mexican male injection drug users deported from the United States. J Urban Health: Bull NY Acad Med 2011;88:104–117
  • Pollini RA, Alvelais J, Gallardo M, Vera A, Lozada R, Magis-Rodriguez C, Strathdee SA. The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend 2009;103:52–58
  • Robertson AM, Lozada R, Vera A, Palinkas LA, Burgos JL, Magis-Rodriguez C, Rangel G, Ojeda VD. Deportation experiences of women who inject drugs in Tijuana, Mexico. Qualitat Health Res 2012;22:499–510
  • Strathdee SA, Davila W, Case P, Firestone M, Brouwer KC, Perez SG, Magis C, Fraga MA. Vivo para consumirla y la consumo para vivir [“I live to inject and inject to live”]: high risk injection behaviors in Tijuana, Mexico. J Urban Health 2005;82:58–73
  • Pollini RA, Lozada R, Gallardgo M, Rosen P, Vera A, Macias A, Palinkas LA, Strathdee SA. Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed-methods study. AIDS Behav 2010;12:679–687
  • Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001. J Urban Health: Bull NY Acad Med 79:556–570
  • CENSIDA, CONADIC, SSA. Manual para la prevencion del VIH/SIDA en usuarios de drogas inyectadas [HIV/AIDS prevention guidelines for injection drug users]. Mexico: Secretariat of Health; 2008
  • Bustamante JG, Izazola JA, Rodriguez-Ajenjo C. Tackling HIV and drug addiction in Mexico. Lancet 2010;376:493–495
  • CENSIDA. Actividades de reducción del daño en usuarios de drogas [Harm reduction activities among drug users]. Internal reports 2006, 2007 and 2008. Mexico
  • FUNSALUD. HIV/AIDS Global Fund. 2014. Available from: http://portal.funsalud.org.mx/?page_id=1727 [last accessed 18 March 2014]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.